IL-12 up-regulates CD40 ligand (CD154) expression on human T cells

被引:0
|
作者
Peng, XH
Remacle, JE
Kasran, A
Huylebroeck, D
Ceuppens, JL
机构
[1] Catholic Univ Louvain, Fac Med, Dept Pathophysiol, Expt Immunol Lab, B-3000 Louvain, Belgium
[2] Catholic Univ Louvain VIB, Lab Cell Growth Differentiat & Dev, B-3000 Louvain, Belgium
来源
JOURNAL OF IMMUNOLOGY | 1998年 / 160卷 / 03期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-12 is a heterodimeric cytokine produced by APC that promotes the development of CD4(+) Thl cells and their IFN-gamma production after TCR/CD3 triggering. We here investigated the capacity,, of IL-ll to modify the expression on T cells of CD40 ligand (CD40L or CD154), a molecule transiently expressed on activated T cells and known to be of utmost importance for cognate interaction with B cells and for activation of dendritic cells and macrophages. Our data demonstrate that IL-12 up-regulates CD40L expression on anti-CD3-activated human peripheral blood T cells, For optimal induction of CD40L. IL-12 synergizes with IL-2 as well as with other costimulatory interactions, such as B7/CD28. The effect of IL-12 was observed at both the protein and the mRNA level, T cells costimulated by IL-12 provided more efficient help for IL-4-dependent B cell proliferation and for Ige; production than when activated in the absence of IL-12. This helper activity was blocked by an mAb against CD40L, indicating that the effect of IL-12 on B cells is mediated indirectly through CD40L. The data thus suggest that the effects of IL-12 on cellular and humoral immune responses are partly mediated through CD40L induction.
引用
收藏
页码:1166 / 1172
页数:7
相关论文
共 50 条
  • [41] Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells
    Couderc, B
    Zitvogel, L
    Douin-Echinard, V
    Djennane, L
    Tahara, H
    Favre, G
    Lotze, MT
    Robbins, PD
    CANCER GENE THERAPY, 1998, 5 (03) : 163 - 175
  • [42] The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: Reciprocal regulation by interleukin (IL)-4 and IL-12
    Lee, BO
    Haynes, L
    Eaton, SM
    Swain, SL
    Randall, TD
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (05): : 693 - 704
  • [43] IL-12 up-regulates T-bet independently of IFN-γ in human CD4+ T cells
    Ylikoski, E
    Lund, R
    Kyläniemi, M
    Filén, S
    Kilpeläinen, M
    Savolainen, J
    Lahesmaa, R
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (11) : 3297 - 3306
  • [44] An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions
    Blumberg, Neil
    Gettings, Kelly F.
    Turner, Chantal
    Heal, Joanna M.
    Phipps, Richard P.
    TRANSFUSION, 2006, 46 (10) : 1813 - 1821
  • [45] Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis
    Jensen, J
    Krakauer, M
    Sellebjerg, F
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (04) : 321 - 328
  • [46] Immunotargeting with CD154 (CD40 ligand) enhances DNA vaccine responses in ducks
    Gares, Sheryl L.
    Fischer, Karl P.
    Congly, Stephen E.
    Lacoste, Stacey
    Addison, William R.
    Tyrrell, D. Lorne
    Gutfreund, Klaus S.
    CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (08) : 958 - 965
  • [47] Production of IL-4 and expression of CD40 ligand by human CD8+ T cells
    Yanagihara, Y
    Kajiwara, K
    Koshio, T
    Basaki, Y
    Ikizawa, K
    Mori, M
    Akiyama, K
    Kawamura, N
    Sakiyama, Y
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (05) : S405 - S411
  • [48] The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
    U. Schönbeck*RID="*"ID="*" Corresponding author.
    P. Libby
    Cellular and Molecular Life Sciences CMLS, 2001, 58 : 4 - 43
  • [49] Excess bone marrow mast cells constitutively express CD154 (CD40 ligand) in Waldenstrom's macroglobulinemia and may support tumor cell growth through CD154/CD40 pathway
    Tournilhac, O
    Santos, DD
    Branagan, A
    Hunter, Z
    Manning, R
    Tai, YT
    Kutok, JL
    Munshi, N
    Anderson, KC
    Treon, SP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 571S - 571S
  • [50] Update on CD40 and CD154 blockade in transplant models
    Zhang, Tianshu
    Pierson, Richard N.
    Azimzadeh, Agnes M.
    IMMUNOTHERAPY, 2015, 7 (08) : 899 - 911